Global Neuromodulation Devices Market by Product (Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators), Application (Neurological Disorders, Pain Management, Respiratory Disorders), End User - Forecast 2024-2030- Product Image

Sale

Global Neuromodulation Devices Market by Product (Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators), Application (Neurological Disorders, Pain Management, Respiratory Disorders), End User - Forecast 2024-2030

Report
186 Pages
March 2024
Region: Global
360iResearch™
ID: 5666253

UP TO €851EUR$875USD£729GBP OFF until Dec 31^st 2024

The Neuromodulation Devices Market size was estimated at USD 8.66 billion in 2023, USD 9.79 billion in 2024, and is expected to grow at a CAGR of 13.54% to reach USD 21.07 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neuromodulation Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neuromodulation Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neuromodulation Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Avanos Medical, Inc., Axonics, Inc., B. Braun SE, Beijing PINS Medical Co., Ltd., Bioventus, Boston Scientific Corporation, LivaNova PLC, Medtronic PLC, Nevro Corp., Second Sight Medical Products Inc., SPR Therapeutics, Inc., Stimwave LLC, and SunMed.

Market Segmentation & Coverage

This research report categorizes the Neuromodulation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Spinal Cord Stimulators
- Transcranial Magnetic Stimulators
- Vagus Nerve Stimulators
Application
- Neurological Disorders
- Pain Management
- Respiratory Disorders
End User
- Hospitals
- Specialty Clinics & Ambulatory Centers

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Neuromodulation Devices Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neuromodulation Devices Market?
What are the technology trends and regulatory frameworks in the Neuromodulation Devices Market?
What is the market share of the leading vendors in the Neuromodulation Devices Market?
Which modes and strategic moves are suitable for entering the Neuromodulation Devices Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Neuromodulation Devices Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of neurological disorders and nerve injuries
5.1.1.2. Growing focus on neuromodulation & neurostimulation technologies
5.1.1.3. Expanding applications of neuromodulation
5.1.2. Restraints
5.1.2.1. High cost of neuromodulation procedures
5.1.3. Opportunities
5.1.3.1. Government support for research on neurological disorders
5.1.3.2. Development of novel neuromodulation devices
5.1.4. Challenges
5.1.4.1. Stringent regulatory frameworks and time-consuming approval processes
5.1.4.2. Lack of technical expertise across the globe
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Neuromodulation Devices Market, by Product

6.1. Introduction
6.2. Deep Brain Stimulators
6.3. Sacral Nerve Stimulators
6.4. Spinal Cord Stimulators
6.5. Transcranial Magnetic Stimulators
6.6. Vagus Nerve Stimulators

7. Neuromodulation Devices Market, by Application

7.1. Introduction
7.2. Neurological Disorders
7.3. Pain Management
7.4. Respiratory Disorders

8. Neuromodulation Devices Market, by End User

8.1. Introduction
8.2. Hospitals
8.3. Specialty Clinics & Ambulatory Centers

9. Americas Neuromodulation Devices Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Neuromodulation Devices Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Neuromodulation Devices Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Aleva Neurotherapeutics SA
13.1.3. Avanos Medical, Inc.
13.1.4. Axonics, Inc.
13.1.5. B. Braun SE
13.1.6. Beijing PINS Medical Co., Ltd.
13.1.7. Bioventus
13.1.8. Boston Scientific Corporation
13.1.9. LivaNova PLC
13.1.10. Medtronic PLC
13.1.11. Nevro Corp.
13.1.12. Second Sight Medical Products Inc.
13.1.13. SPR Therapeutics, Inc.
13.1.14. Stimwave LLC
13.1.15. SunMed
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. NEUROMODULATION DEVICES MARKET RESEARCH PROCESS
FIGURE 2. NEUROMODULATION DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NEUROMODULATION DEVICES MARKET DYNAMICS
FIGURE 7. NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. NEUROMODULATION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. NEUROMODULATION DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. NEUROMODULATION DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. NEUROMODULATION DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. NEUROMODULATION DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. NEUROMODULATION DEVICES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. NEUROMODULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. NEUROMODULATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS & AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 146. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. NEUROMODULATION DEVICES MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Aleva Neurotherapeutics SA
Avanos Medical, Inc.
Axonics, Inc.
B. Braun SE
Beijing PINS Medical Co., Ltd.
Bioventus
Boston Scientific Corporation
LivaNova PLC
Medtronic PLC
Nevro Corp.
Second Sight Medical Products Inc.
SPR Therapeutics, Inc.
Stimwave LLC
SunMed

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	186
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 9.79 Billion
Forecasted Market Value ( USD ) by 2030	$ 21.07 Billion
Compound Annual Growth Rate	13.5%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3283EUR$3,374USD£2,812GBP €3648EUR$3,749USD£3,125GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4159EUR$4,274USD£3,562GBP €4621EUR$4,749USD£3,958GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5034EUR$5,174USD£4,313GBP €5594EUR$5,749USD£4,792GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5910EUR$6,074USD£5,063GBP €6567EUR$6,749USD£5,625GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7661EUR$7,874USD£6,563GBP €8513EUR$8,749USD£7,292GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Neurosurgery Devices Market by Product (Neuroendoscopy Devices, Neuromodulation Devices), Function (Access, Aspirating, Delivery), Application - Forecast 2024-2030

Internal Neuromodulation Devices Global Market Report 2024

Global Neuromodulation Market by Technology (Deep Brain Stimulation, Gastric Stimulation, Sacral Nerve Stimulation), Application (Chronic Pain, Dystonia, Essential Tremor) - Forecast 2024-2030

Global Neuromodulation Market by Type (Internal (Spinal Cord Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation), Application (Tremor, Epilepsy, Parkinson's Disease, Depression, Gastroparesis), and Region - Forecast to 2028

Neuromodulation Devices Market Report 2024-2034